SP2070: Human Serum, Off the Clot, Double Charcoal Treated & Delipidized

SP2070 is a premium-grade human serum, processed off the clot and subjected to double charcoal treatment and delipidization. This specialized serum matrix is designed to remove endogenous hormones and lipids, providing a clean, low-interference background for sensitive diagnostic and analytical applications.

Sourced from off-the-clot human blood, SP2070 maintains native protein profiles while eliminating variables that can affect assay performance. The material is preservative-free, sterile filtered (0.22 µm), and stored at -20°C for stability. Each lot is tested using FDA-approved methods and found non-reactive for HIV 1/2, HBsAg, HCV, and other bloodborne pathogens.

Key Features:

• Off-the-clot human serum for enhanced protein integrity
• Double charcoal treated to reduce hormone levels (T4 ≤ 4.0 µg/dL; TSH ≤ 0.2 µIU/mL; Progesterone ≤ 0.5 ng/mL; Testosterone ≤ 0.2 ng/mL; Estradiol ≤ 10 pg/mL)
• Delipidized to minimize lipid interference in assays
• Sterile filtered and preservative-free
• Ideal for LC-MS, immunoassay, and diagnostic development
• Tested non-reactive for HIV, HCV, HBV, and RPR

Applications:

• Hormone-depleted matrix for endocrine and fertility testing
• Low-lipid background for LC-MS and bioanalytical workflows
• Clean base for calibrators, controls, and diagnostic kit manufacturing
• Clinical research and assay development requiring serum consistency

Request a quote or general inquiry for pricing, COA, or specification sheet.